Cargando…
IL-32 promoter SNP rs4786370 predisposes to modified lipoprotein profiles in patients with rheumatoid arthritis
Patients with rheumatoid arthritis (RA) are at higher risk of developing cardiovascular diseases (CVD). Interleukin (IL)-32 has previously been shown to be involved in the pathogenesis of RA and might be linked to the development of atherosclerosis. However, the exact mechanism linking IL-32 to CVD...
Autores principales: | Damen, Michelle S. M. A., Agca, Rabia, Holewijn, Suzanne, de Graaf, Jacqueline, Dos Santos, Jéssica C., van Riel, Piet L., Fransen, Jaap, Coenen, Marieke J. H., Nurmohamed, Mike T., Netea, Mihai G., Dinarello, Charles A., Joosten, Leo A. B., Heinhuis, Bas, Popa, Calin D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278556/ https://www.ncbi.nlm.nih.gov/pubmed/28134327 http://dx.doi.org/10.1038/srep41629 |
Ejemplares similares
-
High-density lipoprotein cholesterol subfractions HDL2 and HDL3 are reduced in women with rheumatoid arthritis and may augment the cardiovascular risk of women with RA: a cross-sectional study
por: Arts, Elke, et al.
Publicado: (2012) -
Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals
por: Popa, Calin D., et al.
Publicado: (2012) -
Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice
por: Agca, Rabia, et al.
Publicado: (2022) -
DAS28: a useful instrument to monitor infliximab treatment in patients with rheumatoid arthritis
por: van Riel, Piet LCM, et al.
Publicado: (2005) -
Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)